Landing
Presentations at Congresses
Systemic Pegcetacoplan (APL-2)
Intravitreal Pegcetacoplan
To learn more about Apellis clinical trials go to clinicaltrials.gov
Please refer to the U.S. Prescribing Information for EMPAVELI®
Please refer to the U.S. Prescribing Information for SYFOVRE®
The safety and efficacy of the agents for the indications under investigation have not been established. There is no guarantee that the outcome of these studies will result in approval by a Health Authority.
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.